| Ms Colleen Andrea Campbell, MS CCC-SLP | |
|
200 Civic Ave, Salisbury, MD 21804-4599 | |
| (410) 749-1466 | |
| (410) 749-9264 |
| Full Name | Ms Colleen Andrea Campbell |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 200 Civic Ave, Salisbury, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164622023 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 05526 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Colleen Andrea Campbell, MS CCC-SLP 200 Civic Ave, Salisbury, MD 21804-4599 Ph: (410) 749-1466 | Ms Colleen Andrea Campbell, MS CCC-SLP 200 Civic Ave, Salisbury, MD 21804-4599 Ph: (410) 749-1466 |
News Archive
ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today the publication of an important clinical trial demonstrating that patients treated with ArthroCare's Plasma Disc Decompression (PDD) products experienced reduced pain and better quality of life scores compared to patients treated with the current standard care, epidural steroid injections.
A compound that mops up debris of damaged cells from the bloodstream may be the first in a new class of drugs designed to address one of medicine's most difficult challenges - stopping the formation of blood clots without triggering equally threatening bleeding.
In 2007, in an article published in Nature Neuroscience, scientists at the Institute for Research in Biomedicine (IRB Barcelona) headed by Joan Guinovart, an authority on glycogen metabolism, reported that in Lafora Disease (LD), a rare and fatal neurodegenerative condition that affects adolescents, neurons die as a result of the accumulation of glycogen-chains of glucose.
In a study of specially designed peripheral prism glasses for hemianopia patients (blinded in half the visual field in both eyes), scientists found that two-thirds of patients continued to wear the glasses at the end of the study period and beyond, indicating a high level of success.
New research looks at whether clot-busting drugs can safely be given to children who have strokes. The research was released today and will be presented at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21 to April 28, 2012.
› Verified 9 days ago
Michelle H Grbic, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 E Carroll St, Salisbury, MD 21801 Phone: 410-546-6400 | |
Megan Insley, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1213 Emeron Ave, Salisbury, MD 21801 Phone: 410-677-5807 | |
Kristine M Heatwole, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 Prince St, Salisbury, MD 21804 Phone: 410-677-5813 | |
Hannah Susan King, M.S, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Civic Ave, Salisbury, MD 21804 Phone: 410-749-1466 | |
Ms. Felicia A Brockman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 E Carroll St, Salisbury, MD 21801 Phone: 410-546-6400 | |
Denise Theresa Tomey, M.S.CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1336 Belmont Ave, Suite # 502, Salisbury, MD 21804 Phone: 410-546-2894 | |
Amy Kinsey, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Civic Ave, Salisbury, MD 21804 Phone: 410-749-1466 |